China Biologic Products Holdings, Inc. (CBPO) Social Stream
Warning: This security is no longer trading.
In April 2021, China Biologic announced the completion of going private transaction.
China Biologic Products Holdings Inc (CBPO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CBPO.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $119 | $77 | $102.78 | $119.99 | -14.34% |
The Trend in the Analyst Price Target
CBPO's average price target has moved down $0 over the prior 123 days.
Over the past 380 days, CBPO's average upside potential has been -11.88%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-21 | 4 | 119 | 77 | 102.78 | 119.99 | -14.34% |
| 2021-04-17 | 4 | 119 | 77 | 102.78 | 118.00 | -12.9% |
| 2021-04-10 | 4 | 119 | 77 | 102.78 | 118.00 | -12.9% |
| 2021-04-03 | 4 | 119 | 77 | 102.78 | 118.01 | -12.91% |
| 2021-03-20 | 4 | 119 | 77 | 102.78 | 117.85 | -12.79% |
| 2021-03-13 | 4 | 119 | 77 | 102.78 | 117.31 | -12.39% |
| 2021-03-06 | 4 | 119 | 77 | 102.78 | 117.76 | -12.72% |
| 2021-02-27 | 4 | 119 | 77 | 102.78 | 119.54 | -14.02% |
| 2021-02-20 | 4 | 119 | 77 | 102.78 | 119.58 | -14.05% |
| 2021-02-13 | 4 | 119 | 77 | 102.78 | 119.00 | -13.63% |
| 2021-02-06 | 4 | 119 | 77 | 102.78 | 118.30 | -13.12% |
| 2021-01-30 | 4 | 119 | 77 | 102.78 | 117.85 | -12.79% |
| 2021-01-23 | 4 | 119 | 77 | 102.78 | 118.26 | -13.09% |
| 2021-01-16 | 4 | 119 | 77 | 102.78 | 118.34 | -13.15% |
| 2021-01-09 | 4 | 119 | 77 | 102.78 | 118.61 | -13.35% |
| 2021-01-02 | 4 | 119 | 77 | 102.78 | 118.11 | -12.98% |
| 2020-12-26 | 4 | 119 | 77 | 102.78 | 117.87 | -12.8% |
| 2020-12-19 | 4 | 119 | 77 | 102.78 | 118.53 | -13.29% |
| 2020-12-09 | 4 | 119 | 77 | 102.78 | 118.51 | -13.27% |
| 2020-12-07 | 4 | 119 | 77 | 102.78 | 118.72 | -13.43% |
| 2020-11-27 | 2 | 119 | 103 | 111.00 | 118.95 | -6.68% |
| 2020-10-28 | 3 | 115 | 103 | 110.03 | 115.81 | -4.99% |
| 2020-07-17 | 3 | 115 | 103 | 110.03 | 107.43 | 2.42% |
| 2020-04-06 | 3 | 115 | 103 | 110.03 | NA | NA% |
CBPO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 3 | 0 | 0 | 3 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The upside potential (average analyst target price relative to current price) of CBPO is higher than 12.52% of all US stocks.
- The average analyst price target of CBPO is greater than 92.12% of Pharmaceutical Products stocks.
- China Biologic Products Holdings Inc's number of analysts covering the stock is higher than 19.82% of stocks in the mid market cap category.
- CBPO has a lower variance in analysts' estimates than 33.25% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to China Biologic Products Holdings Inc are PAHC, RGLS and ODT.
What is the outlook for CBPO? Use POWR Ratings for clearer insight into price direction.